本文已被:浏览 265次 下载 258次
Received:March 19, 2026 Published Online:August 25, 2026
Received:March 19, 2026 Published Online:August 25, 2026
中文摘要: 目的 探究结肠癌患者血清中可溶性白细胞分化抗原14 亚型(sCD14-ST)、尼曼-匹克C1 型类似蛋白1(NPC1L1)、核糖核苷酸二磷酸还原酶调节亚基M2B(RRM2B)水平与患者临床病理特征的相关性及对术后转移的预测价值。方法 选取2020 年5 月至2022 年5 月长治市人民医院收治的112 例结肠癌患者作为结肠癌组,112例结肠息肉患者作为息肉组,同期112例健康体检者作为对照组。随访2年,依据随访结果分为术后转移组(37 例)及术后未转移组(75 例)。采用酶联免疫吸附试验(ELISA)检测血清sCD14-ST、NPC1L1、RRM2B 水平。比较不同临床特征及不同预后结肠癌患者血清sCD14-ST、NPC1L1、RRM2B水平。分析患者术后转移的影响因素。采用受试者工作特征(ROC)曲线分析血清sCD14-ST、NPC1L1、RRM2B 水平对术后转移的预测价值。结果 与息肉组及对照组比较,结肠癌组患者血清sCD14-ST、NPC1L1 水平升高,血清RRM2B 水平降低(P<0.05)。结肠癌组不同临床特征患者血清sCD14-ST、NPC1L1、RRM2B 水平差异有统计学意义(P<0.05)。术后转移组患者血清sCD14-ST、NPC1L1 水平高于术后未转移组,血清RRM2B 水平低于术后未转移组(P<0.05),血清sCD14-ST、NPC1L1、RRM2B 水平是结肠癌患者术后发生转移的独立影响因素(P<0.05)。血清sCD14-ST、NPC1L1、RRM2B 水平单独及三者联合预测结肠癌患者术后转移的曲线下面积(AUC)分别为0.899(95%CI:0.828~0.948)、0.884(95%CI:0.810~0.937)、0.797(95%CI:0.711~0.867)、0.979(95%CI:0.933~0.997),联合预测的AUC高于三者单独预测的AUC(P<0.05)。结论 结肠癌患者血清sCD14-ST、NPC1L1水平升高,血清RRM2B水平降低,联合监测可用于术后转移的预测。
Abstract:Objective To explore the correlation of serum levels of soluble leukocyte differentiation antigen 14 subtype(sCD14-ST),Niemann-Pick type C1-like 1(NPC1L1),and ribonucleotide reductase regulatory subunit M2B(RRM2B)with clinicopathological features in patients with colon cancer,and analyze their predictive value for postoperative metastasis. Methods A total of 112 patients with colon cancer admitted to Changzhi People's Hospital from May 2020 to May 2022 were selected as the colon cancer group,112 patients with colon polyps as the polyp group,and 112 healthy individuals undergoing routine physical examinations during the same period as the control group. After a 2-year follow-up,patients were categorized based on follow-up results into the postoperative metastasis group(n=37)and the postoperative non-metastasis group(n=75). The serum levels of sCD14-ST,NPC1L1,and RRM2B were measured using enzyme-linked immunosorbent assay(ELISA). The serum levels of sCD14-ST,NPC1L1 and RRM2B in colon cancer patients with different clinical features and different prognoses were compared. The influencing factors of postoperative metastasis in these patients were analyzed. Receiver operating characteristic (ROC)curve analysis was employed to analyze the predictive value of serum sCD14-ST,NPC1L1,and RRM2B levels in predicting postoperative metastasis. Results Compared with the polyp group and control group,serum levels of sCD14-ST and NPC1L1 were higher in the colon cancer group,while the serum level of RRM2B was lower(P<0.05). There were significant differences in serum levels of sCD14-ST,NPC1L1,and RRM2B among colon cancer patients with different clinical features(P<0.05). The serum levels of sCD14-ST and NPC1L1 in the postoperative metastasis group were higher than those in the postoperative non-metastasis group,while the serum level of RRM2B was lower than that in the postoperative non-metastasis group(P<0.05). Serum sCD14-ST,NPC1L1,and RRM2B were independent influencing factors for postoperative metastasis in colon cancer patients(P<0.05). The area under the curve(AUC)of serum sCD14-ST,NPC1L1 and RRM2B levels alone and their combination for predicting postoperative metastasis in patients with colon cancer were 0.899(95%CI:0.828-0.948),0.884(95%CI:0.810-0.937),0.797(95%CI:0.711-0.867)and 0.979(95%CI:0.933-0.997),respectively. The AUC of the combined prediction was significantly higher than those of the three individual predictors(P<0.05). Conclusion The serum levels of sCD14-ST and NPC1L1 in colon cancer patients increase,while the serum level of RRM2B decreases. In addition,the combined detection can be used for the prediction of postoperative metastasis.
keywords: Colon cancer Soluble leukocyte differentiation antigen 14 subtype Niemann-Pick type C1-like 1 Ribonucleotide reductase regulatory subunit M2B Pathological feature Postoperative metastasis
文章编号: 中图分类号:R735.3+5 文献标志码:A
基金项目:山西省基础研究计划项目(20210302124005);山西省留学人员科技活动择优资助项目(20220056);长治市卫生健康委员会科研课题计划项目(202303)
引用文本:
